Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Transpl Int. 2012 Oct;25(10):1032-40. doi: 10.1111/j.1432-2277.2012.01528.x. Epub 2012 Jul 14.
The association between pretransplant dialysis modality and transplant outcomes remains inconsistent. The aim of this study is to address the association between alteration in dialysis modality and post-transplant outcomes. Using Australia and New Zealand Dialysis and Transplant Registry, primary live- and deceased-donor renal transplant recipients (RTR) between 1997 and 2009 were examined. Pre-emptive and multiple-organ transplants were excluded. The association between initial and pretransplant dialysis modality and transplant outcomes were examined. Of the 6701 RTR, 18.6% were initiated-maintained on peritoneal dialysis pretransplant (PD-PD), 9.2% were initiated on PD, but maintained on haemodialysis (HD) pretransplant (PD-HD), 63.3% were HD-HD and 8.9% were HD-PD. PD-HD [odds ratio(OR)1.44, 95% CI 1.21,1.72] and HD-HD (OR1.25, 95% CI 1.12,1.41) were associated with a significantly greater risk of slow graft function compared with the overall mean of the groups, whereas a change in initial dialysis modality from HD to pretransplant PD was associated with higher risk of overall graft failure [hazard ratio(HR)1.19, 95% CI 1.04,1.36) and recipient death (HR1.34, 95% CI 1.13,1.59). Our registry analysis suggest that dialysis modality pretransplant may affect transplant outcomes and future studies evaluating patient selection, choice of modality and/or potential interventions in the pre and post-transplant period may have a beneficial effect on post-transplant outcomes.
移植前透析方式与移植结局的关系仍不一致。本研究旨在探讨透析方式改变与移植后结局的关系。利用澳大利亚和新西兰透析和移植登记处,对 1997 年至 2009 年间进行的初次活体和已故供体肾移植受者(RTR)进行了检查。排除了预先和多器官移植。检查了初始和移植前透析方式与移植结局的关系。在 6701 名 RTR 中,18.6%在移植前接受腹膜透析(PD-PD),9.2%在移植前接受 PD,但维持血液透析(HD)(PD-HD),63.3%是 HD-HD,8.9%是 HD-PD。PD-HD(比值比[OR]1.44,95%置信区间[CI]1.21,1.72)和 HD-HD(OR1.25,95%CI 1.12,1.41)与慢移植物功能的风险显著增加相关与组间平均值相比,而初始透析方式从 HD 改为移植前 PD 与整体移植物失败风险增加相关[风险比(HR)1.19,95%CI 1.04,1.36]和受体死亡(HR1.34,95%CI 1.13,1.59)。我们的登记分析表明,移植前的透析方式可能会影响移植结局,未来评估患者选择、模式选择和/或移植前和移植后潜在干预措施的研究可能对移植后结局产生有益影响。